On this episode of ID the Future, Dr. Michael Behe talks with Casey Luskin about recent findings that support his argument in The Edge of Evolution. Dr. Behe explains why Chloroquine, a drug that treats malaria, presents a good opportunity to study the limits of random mutation and natural selection, and how his conclusions inspired so much backlash — including misrepresentation of his argument — from his critics.
On this episode of ID the Future, Sarah Chaffee interviews Ann Gauger about intelligent design laboratory research. Dr. Gauger explains several key projects, including...
On this episode of ID the Future, bestselling author and Center for Science and Culture director Stephen Meyer introduces an exciting and informative new...
On today's ID the Future, host Casey Luskin continues a deep dive into the mounting hurdles facing origin of life (OOL) research with prebiotic...